KSP Balance Sheet Health
Financial Health criteria checks 6/6
KSP has a total shareholder equity of ₩66.5B and total debt of ₩27.7B, which brings its debt-to-equity ratio to 41.7%. Its total assets and total liabilities are ₩99.3B and ₩32.8B respectively. KSP's EBIT is ₩15.6B making its interest coverage ratio 13.2. It has cash and short-term investments of ₩20.1B.
Key information
41.7%
Debt to equity ratio
₩27.70b
Debt
Interest coverage ratio | 13.2x |
Cash | ₩20.05b |
Equity | ₩66.46b |
Total liabilities | ₩32.79b |
Total assets | ₩99.25b |
Recent financial health updates
Does KSP (KOSDAQ:073010) Have A Healthy Balance Sheet?
May 05KSP (KOSDAQ:073010) Has A Pretty Healthy Balance Sheet
Jan 12Recent updates
KSP's (KOSDAQ:073010) Earnings Are Weaker Than They Seem
Nov 20After Leaping 25% KSP Co., Ltd. (KOSDAQ:073010) Shares Are Not Flying Under The Radar
Aug 12Impressive Earnings May Not Tell The Whole Story For KSP (KOSDAQ:073010)
May 21KSP Co., Ltd.'s (KOSDAQ:073010) Subdued P/E Might Signal An Opportunity
May 12Does KSP (KOSDAQ:073010) Have A Healthy Balance Sheet?
May 05KSP Co., Ltd.'s (KOSDAQ:073010) 31% Share Price Surge Not Quite Adding Up
Apr 07What Do The Returns At KSP (KOSDAQ:073010) Mean Going Forward?
Mar 21KSP Co., Ltd.'s (KOSDAQ:073010) Stock Is Going Strong: Have Financials A Role To Play?
Feb 15KSP (KOSDAQ:073010) Has A Pretty Healthy Balance Sheet
Jan 12What We Make Of KSP's (KOSDAQ:073010) Returns On Capital
Dec 07Financial Position Analysis
Short Term Liabilities: A073010's short term assets (₩55.4B) exceed its short term liabilities (₩28.5B).
Long Term Liabilities: A073010's short term assets (₩55.4B) exceed its long term liabilities (₩4.3B).
Debt to Equity History and Analysis
Debt Level: A073010's net debt to equity ratio (11.5%) is considered satisfactory.
Reducing Debt: A073010's debt to equity ratio has reduced from 64% to 41.7% over the past 5 years.
Debt Coverage: A073010's debt is well covered by operating cash flow (60.5%).
Interest Coverage: A073010's interest payments on its debt are well covered by EBIT (13.2x coverage).